GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Danaher Corp (NYSE:DHR) » Definitions » Shiller PE Ratio

DHR (Danaher) Shiller PE Ratio : 28.47 (As of Apr. 11, 2025)


View and export this data going back to 1986. Start your Free Trial

What is Danaher Shiller PE Ratio?

As of today (2025-04-11), Danaher's current share price is $180.76. Danaher's E10 for the quarter that ended in Dec. 2024 was $6.35. Danaher's Shiller PE Ratio for today is 28.47.

The historical rank and industry rank for Danaher's Shiller PE Ratio or its related term are showing as below:

DHR' s Shiller PE Ratio Range Over the Past 10 Years
Min: 18.83   Med: 34.07   Max: 63.92
Current: 28.47

During the past years, Danaher's highest Shiller PE Ratio was 63.92. The lowest was 18.83. And the median was 34.07.

DHR's Shiller PE Ratio is ranked worse than
57.69% of 78 companies
in the Medical Diagnostics & Research industry
Industry Median: 24.53 vs DHR: 28.47

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Danaher's adjusted earnings per share data for the three months ended in Dec. 2024 was $1.490. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is $6.35 for the trailing ten years ended in Dec. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Danaher Shiller PE Ratio Historical Data

The historical data trend for Danaher's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Danaher Shiller PE Ratio Chart

Danaher Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 47.51 59.12 40.63 37.75 36.14

Danaher Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 37.75 39.78 39.59 43.99 36.14

Competitive Comparison of Danaher's Shiller PE Ratio

For the Diagnostics & Research subindustry, Danaher's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Danaher's Shiller PE Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Danaher's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Danaher's Shiller PE Ratio falls into.


;
;

Danaher Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Danaher's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=180.76/6.35
=28.47

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Danaher's E10 for the quarter that ended in Dec. 2024 is calculated as:

For example, Danaher's adjusted earnings per share data for the three months ended in Dec. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Dec. 2024 (Change)*Current CPI (Dec. 2024)
=1.49/133.1571*133.1571
=1.490

Current CPI (Dec. 2024) = 133.1571.

Danaher Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201503 0.790 99.621 1.056
201506 0.970 100.684 1.283
201509 2.010 100.392 2.666
201512 0.990 99.792 1.321
201603 1.090 100.470 1.445
201606 0.940 101.688 1.231
201609 0.560 101.861 0.732
201612 1.070 101.863 1.399
201703 0.720 102.862 0.932
201706 0.790 103.349 1.018
201709 0.810 104.136 1.036
201712 1.210 104.011 1.549
201803 0.800 105.290 1.012
201806 0.950 106.317 1.190
201809 0.930 106.507 1.163
201812 1.050 105.998 1.319
201903 0.460 107.251 0.571
201906 0.970 108.070 1.195
201909 0.890 108.329 1.094
201912 1.730 108.420 2.125
202003 0.810 108.902 0.990
202006 1.240 108.767 1.518
202009 1.160 109.815 1.407
202012 1.660 109.897 2.011
202103 2.290 111.754 2.729
202106 2.400 114.631 2.788
202109 1.540 115.734 1.772
202112 2.390 117.630 2.705
202203 2.310 121.301 2.536
202206 2.250 125.017 2.397
202209 2.100 125.227 2.233
202212 2.990 125.222 3.179
202303 1.940 127.348 2.028
202306 1.490 128.729 1.541
202309 1.510 129.860 1.548
202312 1.450 129.419 1.492
202403 1.450 131.776 1.465
202406 1.220 132.554 1.226
202409 1.120 133.029 1.121
202412 1.490 133.157 1.490

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Danaher  (NYSE:DHR) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Danaher Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Danaher's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Danaher Business Description

Address
2200 Pennsylvania Avenue, North West, Suite 800W, Washington, DC, USA, 20037-1701
In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Then, through a series of mergers, acquisitions, and divestitures, Danaher now focuses primarily on manufacturing scientific instruments and consumables in the life science and diagnostic industries after the late 2023 divestiture of its environmental and applied solutions group, Veralto.
Executives
Alan G Spoon director 1150 15TH ST NW, WASHINGTON DC 20071
Brian W Ellis officer: Senior Vice President - GC 2200 PENNSYLVANIA AVENUE, NW, WASHINGTON DC 20037
Daniel Raskas officer: VP-Corporate Development 2099 PENNSYLVANIA AVENUE, NORTHWEST, WASHINGTON DC 20006
Georgeann Couchara officer: SVP, Human Resources 2200 PENNSYLVANIA AVENUE, NW, SUITE 800W, WASHINGTON DC 20037
Linda Filler director 2200 PENNSYLVANIA AVE NW, SUITE 800W, WASHINGTON DC 20037
Matthew Mcgrew officer: EVP & Chief Financial Officer 2200 PENNSYLVANIA AVENUE, NW, SUITE 800 W, WASHINGTON DC 20010
Rainer Blair officer: Executive Vice President 2200 PENNSYLVANIA AVENUE, NW, SUITE 800W, WASHINGTON DC 20037
Joakim Weidemanis officer: Executive Vice President 2200 PENNSYLVANIA AVENUE, SUITE 800W, WASHINGTON DC 20037
Walter G Lohr director DANAHER CORP, 2099 PENNSYLVANIA AVE NW 12TH FL, WASHINGTON DC 20006
Teri List director 2200 PENNSYLVANIA AVENUE, SUITE 800W, WASHINGTON DC 20037
Jose-carlos Gutierrez-ramos officer: SVP, Chief Scientific Officer C/O MOMENTA PHARMACEUTICALS, INC., 675 WEST KENDALL STREET, CAMBRIDGE MA 02142
Raymond C Stevens director 2200 PENNSYLVANIA AVENUE, SUITE 800W, WASHINGTON DC 20037
Jennifer Honeycutt officer: Executive Vice President 2200 PENNSYLVANIA AVENUE, SUITE 800W, WASHINGTON DC 20037
Feroz Dewan director C/O ARENA HOLDINGS MANAGEMENT LLC, 119 FIFTH AVENUE - 8TH FLOOR, NEW YORK NY 10003
Mitchell P Rales director, officer: Chairman of Exec. Committee 11790 GLEN ROAD, POTOMAC MD 20854